PERLINDUNGAN HUKUM TERHADAP KONSUMEN ATAS OVERCLAIM MANFAAT KESEHATAN PADA PRODUK NON-OBAT TANPA DUKUNGAN UJI KLINIK
DOI:
https://doi.org/10.35586/jhs.v5i2.13969Keywords:
Perlindungan Konsumen, Overclaim, Uji KlinikAbstract
This study aims to examine the legal construction of consumer protection against health benefit overclaims in non-medicinal supplements lacking clinical trials, as well as the scope of business actors’ liability within the Indonesian legal system. The research employs a normative juridical method, applying both a statutory approach and a conceptual approach. The statutory approach analyzes the hierarchical structure of norms, encompassing Law Number 8 of 1999 on Consumer Protection, the Indonesian Civil Code, and sectoral regulations governing drug and food supervision administered by the Badan Pengawas Obat dan Makanan Republik Indonesia. The conceptual approach is utilized to critically assess the doctrines of overclaim, misrepresentation, duty of care, and the principle of actori incumbit probatio in the allocation of the burden of proof. Primary, secondary, and tertiary legal materials are examined through qualitative analysis using systematic and grammatical interpretation. The study seeks to formulate a coherent legal argument concerning the permissible scope of health claims, the evidentiary standards required for therapeutic representations, and the layered framework of administrative, civil, and criminal liability in consumer protection law, emphasizing legal certainty and substantive justice.
Downloads
References
Ahmad Miru & Sutarman Yodo. Hukum Perlindungan Konsumen, Jakarta: RajaGrafindo Persada, 2008.
Anwar Wahyudi, Iha Haryani Hatta, & Shirly Kumala. “Benchmarking Kondisi Industri Bahan Baku Obat di Dunia”. (2023). https://doi.org/10.58812/sek.v1i03.149.
Azharuddin Nasution. Hukum Perlindungan Konsumen. Jakarta: Diadit Media, 2014.
Bahder Johan Nasution. Metode Penelitian Ilmu Hukum. Bandung: Mandar Maju, 2008.
BPOM. (2023). BPOM Perkuat Lini Pengawasan untuk Tekan Tren Pelanggaran Produk Obat Tradisional, Suplemen Kesehatan, dan Kosmetika. Diakses pada tanggal 26 Februari 2026 dari https://www.pom.go.id/berita/bpom-perkuat-lini-pengawasan-untuk-tekan-tren-pelanggaran-produk-obat-tradisional-suplemen-kesehatan-dan-kosmetika.
BPOM. (2025). SIARAN PERS Nomor HM.01.1 2.04.25.101 Tanggal 29 April 2025 Tentang BPOM Terbitkan Pedoman Uji Stabilitas Suplemen Kesehatan, Permudah Penjaminan Mutu Suplemen Kesehatan Sesuai Masa Simpan. Diakses pada tanggal 26 Februari 2026 dari https://www.pom.go.id/siaran-pers/bpom-terbitkan-pedoman-uji-stabilitas-suplemen-kesehatan-permudah-penjaminan-mutu-suplemen-kesehatan-sesuai-masa-simpan.
BPOM. (2025). SIARAN PERS Nomor HM.01.1.2.07.25.132 Tanggal 17 Juli 2025 Tentang BPOM Dorong Kolaborasi Pengawasan Bertanggung Jawab oleh Masyarakat untuk Kawal Keamanan Obat dan Makanan. Diakses pada tanggal 26 Februari 2026 dari https://www.pom.go.id/siaran-pers/bpom-dorong-kolaborasi-pengawasan-bertanggung-jawab-oleh-masyarakat-untuk-kawal-keamanan-obat-dan-makan.
Bunga Permata Sari, Yudhia Ismail, Kristina Sulatri. “Perlindungan Hukum Terhadap Konsumen Terkait Overclaim Pelaku Usaha Dalam Label Obat Ditinjau Dari Pasal 8 ayat (1) Huruf d Undang-Undang Nomor 8 Tahun 1999 Tentang Perlindungan Konsumen”. (2022). https://doi.org/10.51213/yurijaya.v4i1.71.
David G. Owen. Products Liability Law. St. Paul: West Academic, 2015.
David Lawrence Sackett, Evidence-Based Medicine: How to Practice and Teach EBM. Edinburgh: Churchill Livingstone, 2000.
Eli Febriani, dkk. “Analisis Praktik Endorsement dan Review Produk oleh Influencer terhadap Transaksi Najasy di Media Sosial Perspektif Fikih Muamalah Kontemporer (Studi pada Produk Skincare Non-BPOM Tahun 2024)”. (2025). https://doi.org/10.55606/jimak.v4i2.4707.
Hanny Handayani, dkk. “Analisis Pelanggaran Strategi Pemasaran dalam Praktik Repackaging dan Overclaim Terhadap Keputusan Pembelian Skincare Lokal”. (2025). https://doi.org/10.63822/twzme914.
Heni Marlina, dkk. “Perlindungan Hukum bagi Konsumen atas Overclaim Produk Skincare di Platform E-Commerce”. (2025). https://doi.org/10.32502/mh.v3i1.9415.
Joedy Rodrick Pakaila, Rafael Muhammad Aydin, & Syahira Wanda Abbiyya. “Tren Overclaim Dalam Iklan Industri Kecantikan: Analisis Etika Terapan Pada Produk Skincare Di Indonesia”. (2024). https://doi.org/10.35127/kabillah.v9i2.424.
Lawrence Meir Friedman, Curt D. Furberg, David L. DeMets, & Christopher B. Granger. Fundamentals of Clinical Trials, New York: Springer, 2015.
Lintang Aprilia, Rahayu Subekti, & Sapto Hermawan. “Kajian Precautionary Principle Terhadap Pengelolaan Limbah Medis B3 Pada Fasilitas Layanan Kesehatan”. (2025).
Losianus Harjon, dkk. “Penyebaran Hoaks Dalam Bisnis Digital: Sebuah Analisis Pada Konten Kreator Media Sosial”. (2026). https://doi.org/10.23969/jp.v11i01.42409.
Mason, Philip. Dietary Supplements. London: Pharmaceutical Press, 2012.
Muhammad Yahya Harahap. Hukum Acara Perdata. Jakarta: Sinar Grafika, 2016.
Nadia Firda Ayu Fernanda. “Perlindungan Hukum bagi Konsumen atas Perbuatan Overclaim Pelaku Usaha pada Produk Skincare”. (2025). https://doi.org/10.62383/terang.v2i3.1268.
Peter Mahmud Marzuki. Penelitian Hukum. Jakarta: Kencana, 2010.
Philipus M. Hadjon. Perlindungan Hukum bagi Rakyat Indonesia, Surabaya: Bina Ilmu, 1987.
Rafyanka Ivana Putri Ngabito. “Analisis Pertanggungjawaban Hukum Terhadap Pengedaran Produk Skincare yang Terbukti Overclaim”. (2024). https://doi.org/10.14710/ldjr.7.2024.284-301.
Shidarta. Hukum Perlindungan Konsumen Indonesia, Jakarta: Grasindo, 2006.
Ulfa Husna Dhirah, dkk.“Peningkatan Kualitas Generasi Sadar Kesehatan Reproduksi Remaja Di SMA Negeri 1 Krueng Barona Jaya, Kabupaten Aceh Besar”. (2025).
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike 4.0 International License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
Jurnal Statuta have CC-BY-SA or an equivalent license as the optimal license for the publication, distribution, use, and reuse of scholarly work.
In developing strategy and setting priorities, Jurnal Statuta recognize that free access is better than priced access, libre access is better than free access, and libre under CC-BY-SA or the equivalent is better than libre under more restrictive open licenses. We should achieve what we can when we can. We should not delay achieving free in order to achieve libre, and we should not stop with free when we can achieve libre.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
The licensor cannot revoke these freedoms as long as you follow the license terms.

Jurnal Statuta licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.


